Candeil L. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan‐treated metastases.
Stenvang J. Targeting the topoisomerase I enzyme in cancer cells with acquired resistance to SN-38.
Jensen NF. Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.
Jandu H. Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.